BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8892354)

  • 1. Interleukin-6-associated inflammatory processes in Alzheimer's disease: new therapeutic options.
    Hüll M; Fiebich BL; Lieb K; Strauss S; Berger SS; Volk B; Bauer J
    Neurobiol Aging; 1996; 17(5):795-800. PubMed ID: 8892354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease.
    Hüll M; Strauss S; Berger M; Volk B; Bauer J
    Behav Brain Res; 1996 Jun; 78(1):37-41. PubMed ID: 8793035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alzheimer dementia: more than amyloid plaques and neurofibrillary degeneration].
    Bauer J
    Fortschr Med; 1994 Mar; 112(7):81-4. PubMed ID: 8175096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory mechanisms in Alzheimer's disease.
    Hüll M; Strauss S; Berger M; Volk B; Bauer J
    Eur Arch Psychiatry Clin Neurosci; 1996; 246(3):124-8. PubMed ID: 8739396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.
    Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM
    J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines in Alzheimer's disease.
    Altstiel LD; Sperber K
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(4):481-95. PubMed ID: 1749826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent inhibition of interleukin-6 expression in a human astrocytoma cell line by tenidap.
    Lieb K; Fiebich BL; Hüll M; Berger M; Bauer J
    Cell Tissue Res; 1997 May; 288(2):251-7. PubMed ID: 9082960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenetic factors of Alzheimer disease].
    Bauer J; Hüll M; Berger M
    Z Gerontol Geriatr; 1995; 28(3):155. PubMed ID: 7664189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex.
    Yilmazer-Hanke DM
    Acta Anat (Basel); 1998; 162(1):46-55. PubMed ID: 9789108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease.
    Xia M; Qin S; McNamara M; Mackay C; Hyman BT
    Am J Pathol; 1997 Apr; 150(4):1267-74. PubMed ID: 9094983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease.
    Guo H; Albrecht S; Bourdeau M; Petzke T; Bergeron C; LeBlanc AC
    Am J Pathol; 2004 Aug; 165(2):523-31. PubMed ID: 15277226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of interleukin-6 in cortical plaques of Alzheimer's disease patients may precede transformation of diffuse into neuritic plaques.
    Hüll M; Berger M; Volk B; Bauer J
    Ann N Y Acad Sci; 1996 Jan; 777():205-12. PubMed ID: 8624085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease and Alzheimer-type of cerebral degenerations in Chinese.
    Ng HK
    Clin Exp Neurol; 1994; 31():85-98. PubMed ID: 7586669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia.
    Luterman JD; Haroutunian V; Yemul S; Ho L; Purohit D; Aisen PS; Mohs R; Pasinetti GM
    Arch Neurol; 2000 Aug; 57(8):1153-60. PubMed ID: 10927795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis.
    Sheng JG; Ito K; Skinner RD; Mrak RE; Rovnaghi CR; Van Eldik LJ; Griffin WS
    Neurobiol Aging; 1996; 17(5):761-6. PubMed ID: 8892349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease.
    Dickson TC; Vickers JC
    Neuroscience; 2001; 105(1):99-107. PubMed ID: 11483304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1, neuroinflammation, and Alzheimer's disease.
    Mrak RE; Griffin WS
    Neurobiol Aging; 2001; 22(6):903-8. PubMed ID: 11754997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation.
    Yilmazer-Hanke DM; Hanke J
    Dement Geriatr Cogn Disord; 1999; 10(2):70-6. PubMed ID: 10026378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms.
    Sheng JG; Mrak RE; Griffin WS
    Acta Neuropathol; 1997 Jul; 94(1):1-5. PubMed ID: 9224523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments.
    Su JH; Cummings BJ; Cotman CW
    Brain Res; 1996 Nov; 739(1-2):79-87. PubMed ID: 8955927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.